Wednesday, May 1, 2024

Nutrition Center

No Result

View All Result

Nutrition Center

No Result

View All Result

Home Tag Initiates

Tag: Initiates

Eisai initiates submission of application data of lecanemab under the prior assessment consultation system in Japan with the aim of an earlier regulatory approval

STOCKHOLM, March 4, 2022 /PRNewswire/ -- BioArctic AB:s (publ) (Nasdaq Stockholm: BIOA B) associate Eisai has initiated a submission ...

Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target

Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target

February 24, 2022

The double-blind, placebo managed single and a number of ascending dose Section I scientific trial will consider the protection, tolerability, ...

Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of Lecanemab (BAN2401) For Early Alzheimer’s Disease Under The Accelerated Approval Pathway

September 28, 2021

TOKYO and CAMBRIDGE, Mass., Sept. 27, 2021 /PRNewswire/ -- Eisai Company, Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, ...

Recent Posts

© 2021 Nutrition Center.

No Result

View All Result

© 2021 Nutrition Center.